Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recruitment of Microcirculation Using Albumin 20% and Terlipressin in Patients With Septic Shock: a Randomized Controlled Double-blinded Study.

NCT05080543 is registered in ClinicalTrials.gov with Amany Mousa Salama Muhammed as lead sponsor.

NCT NCT05080543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05080543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recruitment of Microcirculation Using Albumin 20% and Terlipressin in Patients With Septic Shock: a Randomized Controlled Double-blinded Study.
Lead sponsor
Amany Mousa Salama Muhammed
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2021
Completion date
October 31, 2022
Enrollment
36 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock